Microsoft’s $16 billion Nuance bid gets EU antitrust approval By Reuters

BRUSSELS (Reuters) – The European Commission on Tuesday granted Microsoft (NASDAQ:) unconditional antitrust approval for its $16 billion bid for artificial intelligence and speech technology company Nuance Communications (NASDAQ:).

The deal is Microsoft’s second biggest after its $26.2 billion LinkedIn purchase in 2016, and would boost its presence in cloud services for healthcare.

It has already regulatory approval in the United States and Australia, and Reuters reported earlier this month it was set to receive EU approval.

The Commission said its investigation into the deal had concluded that it would not significantly reduce competition in markets for transcription software, cloud services, enterprise communication services, PC operating systems and other products.

“The proposed transaction would raise no competition concerns on any of the markets examined in the European Economic Area,” the Commission said.

U.S.-based Nuance serves 77% of U.S. hospitals and helped launch Apple (NASDAQ:)’s Siri virtual assistant.

The Commission said it had examined issues including the overlap between Microsoft and Nuance’s transcription software activities, and found that they offered “very different products” that, when combined, would continue to face strong competition from other players.

Tech companies have ramped up acquisitions of AI-focused firms as more integrate this technology into their products and services.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.